Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

The epidemiology of cholangiocarcinoma.

Shaib Y, El-Serag HB.

Semin Liver Dis. 2004 May;24(2):115-25. Review.

PMID:
15192785
2.

Risk factors for cholangiocarcinoma.

Ben-Menachem T.

Eur J Gastroenterol Hepatol. 2007 Aug;19(8):615-7. Review.

PMID:
17625428
3.

[Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].

Tischoff I, Tannapfel A.

Zentralbl Chir. 2007 Aug;132(4):300-5. Review. German.

PMID:
17724632
4.

Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.

Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V.

Cancer Epidemiol Biomarkers Prev. 1993 Nov-Dec;2(6):537-44. Review.

5.

Epidemiology of cholangiocarcinoma: an update focusing on risk factors.

Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Wiangnon S, Sripa B, Hong ST.

Cancer Sci. 2010 Mar;101(3):579-85. doi: 10.1111/j.1349-7006.2009.01458.x. Epub 2009 Dec 4. Review.

6.

Intrahepatic cholangiocarcinoma: new insights in pathology.

Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, Fiel MI, Schwartz M, Thung SN.

Semin Liver Dis. 2011 Feb;31(1):49-60. doi: 10.1055/s-0031-1272839. Epub 2011 Feb 22. Review.

PMID:
21344350
7.

Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis.

Chang KY, Chang JY, Yen Y.

J Natl Compr Canc Netw. 2009 Apr;7(4):423-7. Review.

PMID:
19406042
8.

[Cholangiocarcinoma--bile ducts cancer].

Dubaniewicz A, Dubaniewicz A.

Wiad Lek. 2003;56(1-2):57-60. Review. Polish.

PMID:
12901270
9.

Risk factors for cholangiocarcinoma.

Tyson GL, El-Serag HB.

Hepatology. 2011 Jul;54(1):173-84. doi: 10.1002/hep.24351. Review.

10.

Diagnosis and management of cholangiocarcinomas: a comprehensive review.

Yalcin S.

Hepatogastroenterology. 2004 Jan-Feb;51(55):43-50. Review.

PMID:
15011829
11.

Cholangiocarcinoma: risk factors and clinical presentation.

Gatto M, Alvaro D.

Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):363-7. Review.

PMID:
20496549
12.

Clinical presentation, risk factors and staging systems of cholangiocarcinoma.

Plentz RR, Malek NP.

Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):245-52. doi: 10.1016/j.bpg.2015.02.001. Epub 2015 Feb 14. Review.

PMID:
25966425
13.

Cholangiocarcinoma: update and future perspectives.

Gatto M, Bragazzi MC, Semeraro R, Napoli C, Gentile R, Torrice A, Gaudio E, Alvaro D.

Dig Liver Dis. 2010 Apr;42(4):253-60. doi: 10.1016/j.dld.2009.12.008. Epub 2010 Jan 22. Review.

PMID:
20097142
14.

Epidemiology of cholangiocarcinoma.

Bergquist A, von Seth E.

Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):221-32. doi: 10.1016/j.bpg.2015.02.003. Epub 2015 Feb 16. Review.

PMID:
25966423
15.

[Descriptive epidemiology of intrahepatic cholangiocarcinoma].

Tsukuma H.

Nihon Rinsho. 2001 Oct;59 Suppl 6:25-32. Review. Japanese. No abstract available.

PMID:
11761949
16.

Cholangiocarcinoma.

Blechacz BR, Gores GJ.

Clin Liver Dis. 2008 Feb;12(1):131-50, ix. doi: 10.1016/j.cld.2007.11.003. Review.

PMID:
18242501
17.

Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology.

Okuda K, Nakanuma Y, Miyazaki M.

J Gastroenterol Hepatol. 2002 Oct;17(10):1049-55. Review.

PMID:
12201863
18.

Precancerous lesions of intrahepatic cholangiocarcinoma.

Shimonishi T, Sasaki M, Nakanuma Y.

J Hepatobiliary Pancreat Surg. 2000;7(6):542-50. Review.

PMID:
11180885
19.

Intrahepatic cholangiocarcinoma and hepatitis: case study and literature review.

Luh F, Kuei A, Fann P, Chu P, Yen Y.

Anticancer Res. 2009 Aug;29(8):3239-43. Review.

20.

Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.

Rustagi T, Dasanu CA.

J Gastrointest Cancer. 2012 Jun;43(2):137-47. doi: 10.1007/s12029-011-9284-y. Review.

PMID:
21597894

Supplemental Content

Support Center